What does SOBEN Pharma Station do?

SOBEN Pharma Station is a pharmacy in Esneux. Private Limited, started on 9 December 1981, 1 establishment.

What is the address of SOBEN Pharma Station?

The registered office of SOBEN Pharma Station is located at Avenue de la Station 50, 4130 Esneux.

Is SOBEN Pharma Station still active?

Yes. According to the CBE (30 October 2026) SOBEN Pharma Station is active, legal situation “Normale toestand”, started on 9 December 1981.

Is SOBEN Pharma Station registered on Peppol?

Yes, SOBEN Pharma Station is registered on the Peppol network with ID 0208:0422219026.

What is the enterprise number of SOBEN Pharma Station?

The enterprise number of SOBEN Pharma Station is BE0422219026.

When was SOBEN Pharma Station founded?

SOBEN Pharma Station was founded on 9 December 1981.

Who are the directors of SOBEN Pharma Station?

According to the 2025 annual accounts, the directors of SOBEN Pharma Station are: Alphar Esneux SA.

Is SOBEN Pharma Station a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 December 1981; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did SOBEN Pharma Station make in 2025?

SOBEN Pharma Station posted a profit after taxes of € 74,051 in financial year 2025.

What is the revenue of SOBEN Pharma Station?

As a small company, SOBEN Pharma Station is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 265,036.

How much does an employee at SOBEN Pharma Station earn?

The average wage cost per full-time employee at SOBEN Pharma Station was € 40,700 in 2025: staff costs of € 150,461 for 3.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does SOBEN Pharma Station have?

According to the 2025 annual accounts, SOBEN Pharma Station has 3.7 full-time equivalents (FTE).

SOBEN Pharma Station (Private Limited) - Esneux

Dossier SOBEN Pharma Station, printed on 30 October 2026 from databakkes.be/en/0422219026/soben-pharma-station. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 40 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

SOBEN Pharma Station from Esneux, company number BE0422219026, closed financial year 2025 with a result of € 74,051 after tax. For that financial year SOBEN Pharma Station recorded a gross margin of € 265,036 and equity of € 42,294. Compared with financial year 2024, the result moved from € 20,832 to € 74,051. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on April 15, 2026.

What it is worth Growing

€ 42,294

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 74,051

▲ 255% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 32,516

▲ € 25,279 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 70,000 paid out

95 % of the profit went to the shareholders, mostly to ALPHAR ESNEUX (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

3.7

▲ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 150,461

▲ 21% vs 2024

€ 40,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 6,864

▼ 21% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 358,522

▲ 101% vs 2024

€ 46,575 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 184,901

▲ 152% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 52,122

▲ 83% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 150,458 Gross margin 2022: € 150,458 First fiscal year in the series	€ 173,267 Gross margin 2023: € 173,267 ▲ 15% vs 2022 (€ 150,458) Favourable step	€ 173,852 Gross margin 2024: € 173,852 Unchanged (€ 173,267) Favourable step	€ 265,036 Gross margin 2025: € 265,036 ▲ 52% vs 2024 (€ 173,852) Favourable step	▲ 52%
Profit after taxes	€ 38,963 Profit after taxes 2022: € 38,963 First fiscal year in the series	€ 33,637 Profit after taxes 2023: € 33,637 ▼ 14% vs 2022 (€ 38,963) Unfavourable step	€ 20,832 Profit after taxes 2024: € 20,832 ▼ 38% vs 2023 (€ 33,637) Unfavourable step	€ 74,051 Profit after taxes 2025: € 74,051 ▲ 255% vs 2024 (€ 20,832) Favourable step	▲ 255%
Equity	€ 103,774 Equity 2022: € 103,774 First fiscal year in the series	€ 37,411 Equity 2023: € 37,411 ▼ 64% vs 2022 (€ 103,774) Unfavourable step	€ 38,243 Equity 2024: € 38,243 ▲ 2% vs 2023 (€ 37,411) Favourable step	€ 42,294 Equity 2025: € 42,294 ▲ 11% vs 2024 (€ 38,243) Favourable step	▲ 11%
Total debts	€ 334,451 Total debts 2022: € 334,451 First fiscal year in the series	€ 348,239 Total debts 2023: € 348,239 ▲ 4% vs 2022 (€ 334,451) Unfavourable step	€ 301,697 Total debts 2024: € 301,697 ▼ 13% vs 2023 (€ 348,239) Favourable step	€ 690,702 Total debts 2025: € 690,702 ▲ 129% vs 2024 (€ 301,697) Unfavourable step	▲ 129%
Cash	€ 17,008 Cash 2022: € 17,008 First fiscal year in the series	€ 6,771 Cash 2023: € 6,771 ▼ 60% vs 2022 (€ 17,008) Unfavourable step	€ 7,237 Cash 2024: € 7,237 ▲ 7% vs 2023 (€ 6,771) Favourable step	€ 32,516 Cash 2025: € 32,516 ▲ € 25,279 vs 2024 (€ 7,237) Favourable step	▲ € 25,279
Retained profit	€ 83,274 Retained profit 2022: € 83,274 First fiscal year in the series	€ 16,911 Retained profit 2023: € 16,911 ▼ 80% vs 2022 (€ 83,274) Unfavourable step	€ 17,743 Retained profit 2024: € 17,743 ▲ 5% vs 2023 (€ 16,911) Favourable step	€ 21,794 Retained profit 2025: € 21,794 ▲ 23% vs 2024 (€ 17,743) Favourable step	▲ 23%
Dividend	€ 125,000 Dividend 2022: € 125,000 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 ▼ 20% vs 2022 (€ 125,000) Unchanged	€ 20,000 Dividend 2024: € 20,000 ▼ 80% vs 2023 (€ 100,000) Unchanged	€ 70,000 Dividend 2025: € 70,000 ▲ 250% vs 2024 (€ 20,000) Unchanged	▲ 250%
Bank debt	€ 74,067 Bank debt 2022: € 74,067 First fiscal year in the series	€ 126,025 Bank debt 2023: € 126,025 ▲ 70% vs 2022 (€ 74,067) Unfavourable step	€ 178,086 Bank debt 2024: € 178,086 ▲ 41% vs 2023 (€ 126,025) Unfavourable step	€ 358,522 Bank debt 2025: € 358,522 ▲ 101% vs 2024 (€ 178,086) Unfavourable step	▲ 101%
Balance sheet total	€ 438,225 Balance sheet total 2022: € 438,225 First fiscal year in the series	€ 385,650 Balance sheet total 2023: € 385,650 ▼ 12% vs 2022 (€ 438,225) Unchanged	€ 339,940 Balance sheet total 2024: € 339,940 ▼ 12% vs 2023 (€ 385,650) Unchanged	€ 732,996 Balance sheet total 2025: € 732,996 ▲ 116% vs 2024 (€ 339,940) Unchanged	▲ 116%
Employees (FTE)	3.3 Employees (FTE) 2022: 3.3 First fiscal year in the series	3.4 Employees (FTE) 2023: 3.4 ▲ 0.1 vs 2022 (3.3) Unchanged	3.4 Employees (FTE) 2024: 3.4 Unchanged (3.4) Unchanged	3.7 Employees (FTE) 2025: 3.7 ▲ 0.3 vs 2024 (3.4) Unchanged	▲ 0.3

Key figures of SOBEN Pharma Station, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SOBEN Pharma Station?

What happened at SOBEN Pharma Station in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 15, 2026 New annual accounts for financial year 2025: profit of € 74,051 (▲ 255% vs 2024). Source: NBB ↗
Dec 9, 1981 Start of the company according to the CBE. KBO
Oct 1, 1981 New establishment in Esneux. KBO

In short

From € 38,963 profit in 2022 to € 74,051 profit in 2025.

Paid € 59,378 in corporate taxes since 2022.

Best year ever: 2025, with € 74,051 profit.

On average € 71,600 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

ALPHAR ESNEUX 100%

The stake of ALPHAR ESNEUX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

SOBEN Pharma Station

Behind SOBEN Pharma Station is Alphar Esneux SA. The shares are held by ALPHAR ESNEUX (100%).

Directors

According to the 2025 annual accounts

Alphar Esneux SA

Director · represented by Séverine Robeerst

Also active at: SOBEN Pharma Robeerst

Shareholders

ALPHAR ESNEUX

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue de la Station 50

4130 Esneux

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0422.219.026

VAT number

BE 0422.219.026

Registered office

Avenue de la Station 50, 4130 Esneux

Names & denominations

SOBEN Pharma Station

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 December 1981

Peppol

Active · Active since 16 Jul 2026

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

SOBEN Pharma Station

Warning lights

Financials

What happened to SOBEN Pharma Station?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions